Dáil debates
Wednesday, 28 January 2015
Leaders' Questions
12:25 pm
Enda Kenny (Mayo, Fine Gael) | Oireachtas source
It costs €420,000 extra per annum, per patient. The Health Service Executive is right to engage with the drugs company because it is the body that must deal with drug pricing and reimbursement for drugs. The HSE has concluded those negotiations. In view of the fact that this matter was raised by Deputy McEntee, Alexion Pharma-----
No comments